Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Valproic acid may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth. It is not yet known whether valproic acid is more effective than
observation in treating patients with prostate cancer.
PURPOSE: This randomized phase II trial is studying how well valproic acid works in treating
patients with progressive, non-metastatic prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins